A longitudinal diffusion tensor MRI study of the cervical cord and brain in amyotrophic lateral sclerosis patients

Agosta, F.; Rocca, M. A.; Valsasina, P.; Sala, S.; Caputo, D.; Perini, M.; Salvi, F.; Preiie, A.; Filippi, M.
January 2009
Journal of Neurology, Neurosurgery & Psychiatry;Jan2009, Vol. 80 Issue 1, p53
Academic Journal
Objective: To define the temporal evolution of intrinsic tissue damage and atrophy in the cervical cord and the brain portion of the corticospinal tracts (CST) from patients with amyotrophic lateral sclerosis (ALS). Methods: Conventional and diffusion tensor (DT) magnetic resonance imaging (MRI) of the cervical cord and brain were obtained from 17 ALS patients and 20 controls, at baseline and after a mean follow-up of 9 months. The following measurements were assessed: (a) cervical cord cross-sectional area, average mean diffusivity (MD) and average fractional anisotropy (FA); and (b) CST T2-visible hyperintensities, average MD and Results: During the follow-up, ALS patients showed a significant decrease in cord area (p = 0.003) and cord average FA (p = 0.01), and a significant increase in cord average MD (p = 0.01). In ALS patients, longitudinal changes of diffusivity measurements were not associated with cord area changes. At baseline, brain CST average MD was significantly higher in ALS patients compared with controls (p = 0.001). Brain CST diffusivity measurements remained stable over time in ALS patients and did not correlate with cord damage. Conclusions: This study shows that progressive tissue loss and injury to the remaining tissue occur in the cervical cord of ALS patients and that these two features of ALS-related pathology are not strictly interrelated. Cord pathology in ALS patients is likely to be independent of brain changes, indicating that imaging the cervical cord may be a useful adjunctive tool to monitor ALS evolution.


Related Articles

  • Treatment of amyotrophic lateral sclerosis — What is the next step? Ludolph, A.C. // Journal of Neurology;Dec2000 Supplement 6, Vol. 247, pVI13 

    Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease which was thought to be untreatable. However, recent evidence in both experimental animals and men indicates that antiglutamatergic strategies are the first to have an influence on its pathogenesis and slow down the disease...

  • Genetics of amyotrophic lateral sclerosis. Robberecht, W. // Journal of Neurology;Dec2000 Supplement 6, Vol. 247, pVI2 

    The genetic cause of amyotrophic lateral sclerosis (ALS) is known in a minority of cases. Mutations in SOD1, the gene encoding a superoxide dismutase on chromosome 21, are indeed found in 20% of familial ALS patients, who constitute only 5 or 10% of all ALS patients. In rare cases, a mutation in...

  • Amyotrophic Lateral Sclerosis. Rowland, Lewis P.; Shneider, Neil A. // New England Journal of Medicine;05/31/2001, Vol. 344 Issue 22, p1688 

    Reports on advances in genetics which have accelerated the pace of research of amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease, with a promise of more effective treatment. Definition of the disease; Diagnosis of ALS; Proposed underlying causes of ALS; Histopathological features of...

  • Motor neuron disease.  // Journal of Neurology;May2006 Supplement 2, Vol. 253, pII97 

    The article presents abstracts of medical research related to motor neuron diseases. They include "P381 SERPINA3 signal region A/T polymorphism and risk of sporadic amyotrophic lateral sclerosis in a Polish population," "Epidemiology of ALS in Cuba: a pilot study in Havana," and "Elevated serum...

  • Supporting people with motor neurone disease. Barry, Mel // British Journal of Neuroscience Nursing;Jan2009, Vol. 5 Issue 1, p42 

    The article discusses the efforts of the Motor Neurone Disease (MND) Association to help people with MND in Great Britain. It explains that such disease affects the motor neurones that deliver messages from the brain to the muscles which makes people unable to walk, talk or feed themselves. The...

  • New culprit found in Lou Gehrig's disease; second 'bad' gene is linked to damaged cell buildup, paralysis in ALS.  // Biomedical Market Newsletter;11/21/2011, Vol. 21, p56 

    The article discusses the findings of the study about the impact of the genes, sequestosomel and ubiquilin2 in patients with amyotrophic lateral sclerosis (ALS and Lou Gehrig's disease) in Chicago, Illinois. According to the study, patients become paralyzed because they accumulate abnormally in...

  • Executive deficits, not processing speed relates to abnormalities in distinct prefrontal tracts in amyotrophic lateral sclerosis. Pettit, Lewis D.; Bastin, Mark E.; Smith, Colin; Bak, Thomas H.; Gillingwater, Thomas H.; Abrahams, Sharon // Brain: A Journal of Neurology;Nov2013, Vol. 136 Issue 11, p3290 

    Cognitive impairment in amyotrophic lateral sclerosis is characterized by deficits on tests of executive function; however, the contribution of abnormal processing speed is unknown. Methods are confounded by tasks that depend on motor speed in patients with physical disability. Structural and...

  • Elevated Serum Ferritin Is Associated with Reduced Survival in Amyotrophic Lateral Sclerosis. Nadjar, Yann; Gordon, Paul; Corcia, Philippe; Bensimon, Gilbert; Pieroni, Laurence; Meininger, Vincent; Salachas, François; Guillemin, Gilles J. // PLoS ONE;Sep2012, Vol. 7 Issue 9, Special section p1 

    Background: Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder caused by the loss of motor neurons. Its etiology remains unknown, but several hypothesis have been raised to explain motor neuron death, including oxidative stress. Dysregulation of cellular iron metabolism can lead...

  • Pulmonary function tests in patients with amyotrophic lateral sclerosis and the association between these tests and survival. Mousavi, Seyed-Ali Javad; Zamani, Babak; Shahmiri, Shahab Shahabi; Rohani, Mohammad; Ali Shahidi, Gholam; Mostafapour, Elyas; Hemasian, Helia; Raji, Hanieh // Iranian Journal of Neurology;2014, Vol. 13 Issue 3, p131 

    Background: The rapidity of progression of amyotrophic lateral sclerosis (ALS) to death or respiratory failure impacts patients, clinicians, and clinical investigators. The aim of this study is to evaluate of the pulmonary function tests (PFTs) in patients with ALS and the association between...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics